They work through completely different mechanisms and no contraindication is listed in UK prescribing information for either treatment
Real Results Our clients say it best
4045 Linagliptin is the only DPP4 inhibitor excreted primarily via non-renal, and no dose adjustment is necessary in patients with CKD
The application breaks through the limitation that existing hormone replacement therapy and assisted reproductive technology can only treat symptoms or solve the problem of fertility, provides a first drug intervention strategy which can fundamentally delay the process of follicle depletion, and fills the blank in the field of ovarian aging treatment
Patients should be open to pairing treatment with nutrition guidance, physical activity, and healthy routines
The disease severity was classified into four grades: healthy (H, green), light symptoms (L, pale green), severe symptoms (S, orange-yellow), or completely dead (D, red)